home All News open_in_new Full Article

Novo Nordisk engorda sus benefcios hasta los 7.441 millones de euros

La farmacéutica danesa Novo Nordisk, que domina el mercado mundial de los tratamientos contra la obesidad con Ozempic como su fármaco estrellas, presentó este miércoles un beneficio neto de 55.537 millones de coronas (7.441 millones de euros) en el primer semestre, un 22 % más interanual. Las ventas netas ascendieron a 154.944 millones de coronas […] The post Novo Nordisk engorda sus benefcios hasta los 7.441 millones de euros appeared first on Radio Intereconomía.


today 8 d. ago attach_file Politics

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics


ID: 53452979
Add Watch Country

arrow_drop_down